Science & Enterprise subscription

Follow us on Twitter

  • Many thanks @deansguide for the shout-out and all of your good work for lung health. I just report on stuff. Enjoy… https://t.co/nrNcveHCJM
    about 14 hours ago
  • A company developing 3-D printed outer ear tissue received a rare pediatric disease designation on its treatment de… https://t.co/Iya45fwEl2
    about 14 hours ago
  • New post on Science and Enterprise: Bioprinting Ear Tissue Tagged Rare Disease Treatment https://t.co/Cr90bNUF2E #Science #Business
    about 14 hours ago
  • A federally-funded research and entrepreneurship center is underway to adapt and commercialize geothermal energy te… https://t.co/tD0lFPqXtp
    about 19 hours ago
  • New post on Science and Enterprise: University Opens Geothermal Entrepreneurship Center https://t.co/f4gbAkqFeI #Science #Business
    about 19 hours ago

Please share Science & Enterprise

In Case You Missed It …

(tigerlily713, Pixabay)

12 August 2018. Many of today’s cancer drugs are given with intravenous infusions to bypass digestive acids and enzymes that degrade and interfere with the active ingredients. We reported last week on a team at University of Colorado’s medical campus in Denver proposing a way to formulate cancer therapies as oral drugs. Their technique — use the components in milk that enable mothers to pass antibodies to their babies, shielded from the digestive system. NIH is funding the research with a 4-year award.

For this task, the researchers plan to harness exosomes, a topic we’ve written on a few times recently. Exosomes are tiny — 40 to 150 nanometer — lipid-membrane containers in cells that gather up and secrete cytoplasm, the gel-like material outside the cell nucleus. While originally believed to carry out waste removal and other maintenance tasks, exosomes are shown in recent years to perform useful delivery functions carrying proteins and genetic material to other cells, and drawing increased attention from a range of biological disciplines.

Here are other stories we covered last week:

*     *     *

Please share Science & Enterprise ...
error

Comments are closed.